Literature DB >> 6017170

A screening test for Wilson's disease and its application to psychiatric patients.

D W Cox.   

Abstract

Varied modes of onset make the early diagnosis of Wilson's disease difficult. A deficiency of serum ceruloplasmin, usually characteristic of the disease, was used as the basis for a screening test. Simple test materials and provision for handling about 50 plasma samples simultaneously made this test feasible for large-scale screening.The screening test was applied to 336 persons hospitalized for psychiatric disorders, to detect patients with Wilson's disease before the classical symptoms appeared. Two patients with ceruloplasmin levels below the normal limits were detected but did not have Wilson's disease. Further application of the screening test to relatives of patients known to have Wilson's disease and to individuals with any symptoms of the disease (hepatic disease, extrapyramidal dysfunction, psychiatric disorders, behaviour problems in children) would aid in early diagnosis and more effective treatment.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6017170      PMCID: PMC1935894     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  8 in total

1.  PENICILLAMINE THERAPY FOR HEPATOLENTICULAR DEGENERATION.

Authors:  I STERNLIEB; I H SCHEINBERG
Journal:  JAMA       Date:  1964-09-07       Impact factor: 56.272

2.  The diagnosis of Wilson's disease in asymptomatic patients.

Authors:  I STERNLIEB; I H SCHEINBERG
Journal:  JAMA       Date:  1963-03-02       Impact factor: 56.272

3.  Effect of estrogens on copper metabolism in Wilson's disease.

Authors:  J L GERMAN; A G BEARN
Journal:  J Clin Invest       Date:  1961-03       Impact factor: 14.808

4.  A rapid screening test for deficiency of plasma ceruloplasmin and its value in the diagnosis of Wilson's disease.

Authors:  P AISEN; J B SCHORR; A G MORELL; R Z GOLD; I H SCHEINBERG
Journal:  Am J Med       Date:  1960-04       Impact factor: 4.965

5.  The association of hepatolenticular degeneration with schizophrenia. A review of the literature and case report.

Authors:  A W Beard
Journal:  Acta Psychiatr Scand       Date:  1959       Impact factor: 6.392

6.  Alteration of copper metabolism in chlorpromazine-treated cases.

Authors:  H AZIMA; A RICHMAN
Journal:  AMA Arch Neurol Psychiatry       Date:  1956-02

7.  Genetic and biochemical aspects of Wilson's disease.

Authors:  A G BEARN
Journal:  Am J Med       Date:  1953-10       Impact factor: 4.965

8.  Factors influencing serum ceruloplasmin levels in normal individuals.

Authors:  D W Cox
Journal:  J Lab Clin Med       Date:  1966-12
  8 in total
  2 in total

1.  A genetic study of Wilson's disease: evidence for heterogeneity.

Authors:  D W Cox; F C Fraser; A Sass-Kortsak
Journal:  Am J Hum Genet       Date:  1972-11       Impact factor: 11.025

Review 2.  Psychiatric manifestations in Wilson's disease: possibilities and difficulties for treatment.

Authors:  Tomasz Litwin; Petr Dusek; Tomasz Szafrański; Karolina Dzieżyc; Anna Członkowska; Janusz K Rybakowski
Journal:  Ther Adv Psychopharmacol       Date:  2018-03-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.